We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The U.S. FDA announced it approved a new drug, Noxafil (posaconazole), to prevent fungal infections caused by certain molds and yeast-like fungus called Aspergillus and Candida.
South Africa's government is deeply concerned after warnings by medical experts that an outbreak of extremely drug resistant tuberculosis (XDR TB) may have a severe impact on mortality in a country where health professionals are struggling to stem the tide of HIV/AIDS.
When tested in mice and ferrets, experimental vaccines based on live, weakened versions of different strains of the H5N1 avian influenza virus were well-tolerated and protected the animals from a deadly infection with naturally occurring H5N1 flu viruses.
Biogen Idec and mondoBIOTECH AG, a private Swiss biotechnology company, announced the signing of an exclusive collaboration and license agreement for Biogen Idec to develop, manufacture and commercialize Aviptadil, a clinical compound for the treatment of Pulmonary Arterial Hypertension (PAH).
Icelandic generic pharmaceuticals company Actavis said that it has received a warning letter from the FDA relating to the company's solid oral dose manufacturing facility in New Jersey, US.
The
Bill & Melinda Gates Foundation has announced several grants totaling $68.2 million to help accelerate research on neglected tropical diseases that are transmitted by parasites and worms and affect hundreds of millions of people every year in Africa.